Guidelines

ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management

ATS 2026 discussions focused on the complex etiologies and management of bronchiectasis and NTM pulmonary disease, highlighting updated guideline recommendations.

EASL 2026 Consensus: AATD-Liver Disease Management Standardised

A new consensus statement from EASL 2026 aims to standardise the diagnosis and management of Alpha-1 Antitrypsin Deficiency (AATD) related liver disease.

2025 AHA/ACC Hypertension Guidelines: What GPs Need Now

The 2025 AHA/ACC hypertension guidelines update prescribing priorities. Here is what the evidence says about antihypertensive management today.

JAK Inhibitors in RA: 2025 EULAR Safety Update Redraws Risk Guidance

The 2025 EULAR RA update revises JAK inhibitor safety guidance, with implications for prescribing in higher-risk patients.